Harwood Feffer LLP Announces Investigation of Spectrum Pharmaceuticals, Inc.

 Harwood Feffer LLP Announces Investigation of Spectrum Pharmaceuticals, Inc.

PR Newswire

NEW YORK, March 19, 2013

NEW YORK, March 19, 2013 /PRNewswire/ --Harwood Feffer LLP (www.hfesq.com) is
investigating potential claims against the board of directors of Spectrum
Pharmaceuticals, Inc. ("Spectrum" or the "Company") (NASDAQ: SPPI), concerning
whether the board has breached its fiduciary duties to shareholders.

(Logo: http://photos.prnewswire.com/prnh/20120215/MM54604LOGO)

On March 12, 2013, the Company announced that sales of its drug, FUSILEV,
would be significantly lower during 2013 due to changes in market demand for
FUSILEV. As a result, the Company decreased its 2013 revenue guidance from
approximately $300 million to as low as $160 million.

On this news, Spectrum shares lost more than 35% of their value in one day of
trading to close at $7.79 per share on March 13, 2013, down from $12.43 per
share at close on March 12, 2013.

Our investigation concerns whether the Company board of directors has breached
its fiduciary duties to shareholders, grossly mismanaged the Company, and/or
committed abuses of control in connection with the foregoing.

If you own Spectrum shares and wish to discuss this matter with us, or have
any questions concerning your rights and interests with regard to this matter,
please contact:

Robert I. Harwood, Esq.
Matthew M. Houston, Esq.
Benjamin I. Sachs-Michaels, Esq.
Harwood Feffer LLP
488 Madison Avenue
New York, New York 10022
Phone Numbers:   (877) 935-7400
                 (212)935-7400
Email: bsachsmichaels@hfesq.com
Website: http://www.hfesq.com

Harwood Feffer has been representing individual and institutional investors
for many years, serving as lead counsel in numerous cases in federal and state
courts. Please visit the Harwood Feffer LLP website (http://www.hfesq.com) for
more information about the firm.

Attorney Advertising. © 2013 Harwood Feffer LLP. The law firm responsible for
this advertisement is Harwood Feffer LLP (www.hfesq.com). Prior results do not
guarantee or predict a similar outcome with respect to any future matter.



SOURCE Harwood Feffer LLP

Website: http://www.hfesq.com
 
Press spacebar to pause and continue. Press esc to stop.